LIVE
Urban CompanyGMP +₹65 (+14.0%)PowericaGMP +₹30 (+7.5%)Tipco EngineeringGMP +₹18 (+16.1%)Speciality MedicinesGMP +₹22 (+22.2%)Novus LoyaltyGMP +₹8 (+10.5%)CMPDIGMP +₹4 (+2.3%)Nifty 5022,386 ▲ 0.42%Sensex73,651 ▲ 0.38%Bank Nifty47,832 ▲ 0.61%Nifty IT36,104 ▼ 0.24%Urban CompanyGMP +₹65 (+14.0%)PowericaGMP +₹30 (+7.5%)Tipco EngineeringGMP +₹18 (+16.1%)Speciality MedicinesGMP +₹22 (+22.2%)Novus LoyaltyGMP +₹8 (+10.5%)CMPDIGMP +₹4 (+2.3%)Nifty 5022,386 ▲ 0.42%Sensex73,651 ▲ 0.38%Bank Nifty47,832 ▲ 0.61%Nifty IT36,104 ▼ 0.24%

IPOGenie was built with a single mission: to give every Indian retail investor the same quality of IPO intelligence that was previously available only to institutional players. We aggregate, verify, and present IPO data in the clearest possible format — so you can make faster, more informed investment decisions.

What We Track

Every Mainboard and SME IPO on NSE and BSE — from DRHP filing through listing and post-listing performance. Over 300+ IPOs tracked annually.

Who We Serve

Retail investors, HNIs, financial advisors, and market researchers across India — anyone who wants reliable, unbiased IPO data and analysis.

Our Data Standards

All IPO data is sourced from SEBI filings, official exchange portals, and verified registrar websites. GMP data is clearly labelled as unofficial/unregulated.

Editorial Independence

Our IPO ratings (Subscribe/Neutral/Avoid) are independent editorial opinions. We are not influenced by investment banks, IPO companies, or brokers.

Advertiser Disclosure

Some links on IPOGenie — particularly to stock broker platforms — are affiliate links. When you open a Demat account through an IPOGenie affiliate link, we may earn a commission from the broker. This commission comes at no extra cost to you and does not affect our broker ratings or editorial reviews. Our reviews are based on independent research, user feedback, and objective assessment of each broker's features and charges. We prominently disclose when content is sponsored.

Contact Us

Editorial & Content

For IPO data corrections, review feedback, or editorial queries: editorial@ipogenie.in

Partnerships & Advertising

For broker partnerships, sponsored content, or API access: partnerships@ipogenie.in

SME IPO Advisory

For companies planning an SME IPO and seeking advisory services: sme@ipogenie.in

Telegram Community

Join our Telegram channel for daily IPO updates: @ipogenie_official